Intra-day Stock Recommendation [-]
Script Name Time Call No Buy/Sell Enter Between 1st Target 2nd Target Stop Loss High/Low Remark
Weekly Stock Recommendation [26-07-2021 to 30-07-2021] Don't Tread
Script Name Call No Buy/Sell CMP 1st Target 2nd Target Stop Loss High/Low Remark
AXISBANK W-1 Buy 755 768 785++ 748 - SL HIT
LT W-2 Buy 1611 1635 1649++ 1600 - SL HIT
TATAMOTOR W-3 Buy 295 305 310++ 290 - SL HIT
DRREDDY W-4 Buy 5422 5554 5630++ 5400 - SL HIT
INDUSINDBK W-5 Buy 989 1040 1060++ 976 - SL HIT
MGL W-6 Buy 1144 1176 1196++ 1130 - SL HIT
Mainline IPO
Company Name Open Date Close Date Issue Size Issue Price Lot Size Mini App Allotment Status
Windlas Biotech Limited IPO Details 04-08-2020 06-08-2020 ₹ 401.54 Cr ₹ 448 - ₹ 460 30 ₹ 13,800 -
Rolex Rings Limited IPO Details 28-07-2020 30-07-2020 ₹ 700 Cr ₹ 960 - 970 15 ₹ 14,550 -
Glenmark Life Sciences Limited IPO Details 27-07-2020 29-07-2020 ₹ 1513.60 Cr ₹ 695-720 20 ₹ 14,400 -
Tatva Chintan Pharma Chem Limited IPO Details 16-07-2021 20-07-2021 ₹ 500 Cr ₹ 1073-1083 13 ₹ 14,079 Available
SME IPO
Company Name Open Date Close Date Issue Size Issue Price Lot Size Mini App Allotment Status
Network People Services Technologies Limited IPO Details 28-07-2020 02-08-2020 ₹ 13.70 Cr ₹ 76 - ₹ 80 1600 ₹ 1,28,000 -
Rex Pipes and Cables IPO Details 28-07-2020 02-08-2020 ₹ 6.24 Cr ₹ 26 4000 ₹ 1,04,000 -
Gretex Corporate Services Ltd IPO Details 27-07-2020 30-07-2020 ₹ 5.13 Cr ₹ 170 800 ₹ 1,36,000 -

Dr Lalchandani Labs Limited IPO Details

Dr Lalchandani Labs Limited was established in 2011, Delhi based Dr. Lalchandani Labs Limited is a provider of diagnostic and related health-care tests. Through its integrated network, the company offers patients and health-care providers a broad range of diagnostic and related health-care tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

Company is formed to set up, engage, collaborate, acquire, purchase, maintain, open collection centres, conduct, manage, administer, own, run laboratories for the purposes of carrying out pathological investigations of various branches of Bio-Chemistry, Hematology, Histopathology, Microbiology, Electrophoresis, , Virology, Cytology, other pathological Investigations and Immunoassay, Immuno-Histochemistry, Molecular Pathology, Dna & Genetic Testing etc. They are a provider of diagnostic and related healthcare tests and services in Delhi/NCR. Through our integrated network, They offer patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

Company customers include individual patients, hospitals and other healthcare providers and corporate customers. Diagnostic healthcare testing is an essential element in the delivery of healthcare services, as it provides healthcare service providers with useful information for the diagnosis and treatment of diseases. Company is NABL Accredited Lab has established itself within Delhi/NCR with 5 (Five) Self-Sufficient Labs and multiple collection centers. Company Incubates many Fully Automatic Machines from Only reputed Global suppliers like Siemens, Ortho (J&J), Trans Asia, GE etc.
Dr Lalchandani Labs Limited IPO Details
Issue Open 25-04-2018
Issue Close 27-04-2018
Allotment Date 04-05-2018
Unblocked Amount 07-05-2018
Listing Date 09-05-2018
Issue Share 14,00,000 Total Equity Share
72,000 Reserved by Market Maker
13,28,000 Equity Share
Issue Size ₹ 4.20 Cr
IPO Price Band ₹ 30
Minimum Share Bid 4000
Minimum Investment Amount [Rs]  ₹ 1,20,000
Face Value ₹ 10
Retail Allocation 50%
Listing On BSE SME
Premium [Per Share] NA
Average Earning Per Share NA
Expected Listing Gain ₹ -


Dr Lalchandani Labs Limited IPO Financial details [in Rs, Cr]
Financial Year Total Revenue Total Expenses Profit After Tax
FY-2013 1.22 1.20 0.02
FY-2014 1.41 1.37 0.04
FY-2015 1.93 1.61 0.32
FY-2016 3.03 2.71 0.32
FY-2017 4.62 3.91 0.71
Aug-FY-2017 2.16 1.34 0.82
Jan-FY-2018 2.05 1.72 0.24


Dr Lalchandani Labs Limited IPO Subscription Details
As on Date QIB/NII RII Total
Shared Offred 6,64,000 6,64,000 13,28,000
Day-1 [25-04-2018] 1,68,000 [0.25] 1,48,000 [0.22]3,16,000 [0.24]
Day-2 [26-04-2018] 10,56,000 [1.60] 9,96,000 [1.5] 20,52,000 [1.55]
Day-3 [27-04-2018] 21,52,000 [3.25] 40,72,000 [6.14] 62,24,000 [4.69]
Dr Lalchandani Labs Limited IPO Valuation Details
Earnings Per Share [EPS] ₹ 1.01
Price/Earnings [P/E] Ratio 15.06
Return on Net Worth [RoNW] 0.07 %
Net Asset Value [NAV] ₹ 15.21 Per Share
Dr Lalchandani Labs Limited IPO Contact Details
Dr Lalchandani Labs Limited
M-20 Basement,
Greater Kailash-1,
New Delhi 110048
Tel: 011 49057058
Email id: info@lalchandanipathlab.com
Website: www.lalchandanipathlab.com
Registrar of Dr Lalchandani Labs Limited IPO
CAMEO CORPORATE SERVICES LTD.
Submaramanian Building, 1 Club House Road,
Chennai 600 002.
Tel No.: +91-44-2846 0390/1989
Fax No.: +91-44-2846 0129
E-mail ID: cameo@cameoindia.com
Website: www.cameoindia.com
Contact Person: Mr. R. D. Ramasamy
SEBI Registration No: INR000003753
Lead Managers of Dr Lalchandani Labs Limited IPO
NAVIGANT CORPORATE ADVISORS LIMITED
423, A Wing, Bonanza, Sahar Plaza Complex,
J B Nagar, Andheri Kurla Road, Andheri East,
Mumbai-400 059
Tel No. +91-22-41204837
Email Id- navigant@navigantcorp.com
Investor Grievance Email: info@navigantcorp.com
Website: www.navigantcorp.com
SEBI Registration Number: INM000012243
Contact Person: Mr. Sarthak Vijlani
Dr Lalchandani Labs Limited IPO Grey Market Premium
Check Grey Market Premium :- Click Here
Dr Lalchandani Labs Limited IPO Allotment Status
Check Allotment Status :- Click Here
Live Subscription for Dr Lalchandani Labs Limited IPO
Check Live Subscription :- Click Here
Download Dr Lalchandani Labs Limited IPO DRHP & ASBA e-Forms
Download DRHP :- Click Here to Download
Download e-Forms BSE:- Click Here to Download
Dr Lalchandani Labs Limited IPO Recommendations
Live IPO Team Recommendation:- Neutral

0 Response to "Dr Lalchandani Labs Limited IPO Details"

Post a Comment